Cellular Dynamics International, Inc. University Research ParkCellular Dynamics International, Inc. • July 19th, 2013 • Biological products, (no disgnostic substances)
Following the termination of the Fifth Amended and Restated Shareholders Agreement, dated as of November 1, 2012, by and among Cellular Dynamics International, Inc., a Wisconsin corporation (the “Company”), and the individuals and entities who have executed a counterpart signature page thereto, as amended (the “Shareholders Agreement”), and in consideration of the consent by Sixth Floor Investors LP to such termination, for so long as Sixth Floor Investors LP beneficially owns at least 10% of the shares of outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company, the Company shall use its best efforts to cause the Company’s Board of Directors (the “Board”) to nominate and recommend to the shareholders of the Company the election of one nominee designated by Sixth Floor Investors LP at any meeting of the shareholders of the Company (or in any resolution by written consent in lieu thereof) (a) at which nominees are being considered for election to the Bo
